Article

WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl- cotransporters required for normal blood pressure homeostasis.

Department of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 12/2005; 102(46):16777-82. DOI: 10.1073/pnas.0508303102
Source: PubMed

ABSTRACT WNK1 and WNK4 [WNK, with no lysine (K)] are serine-threonine kinases that function as molecular switches, eliciting coordinated effects on diverse ion transport pathways to maintain homeostasis during physiological perturbation. Gain-of-function mutations in either of these genes cause an inherited syndrome featuring hypertension and hyperkalemia due to increased renal NaCl reabsorption and decreased K(+) secretion. Here, we reveal unique biochemical and functional properties of WNK3, a related member of the WNK kinase family. Unlike WNK1 and WNK4, WNK3 is expressed throughout the nephron, predominantly at intercellular junctions. Because WNK4 is a potent inhibitor of members of the cation-cotransporter SLC12A family, we used coexpression studies in Xenopus oocytes to investigate the effect of WNK3 on NCC and NKCC2, related kidney-specific transporters that mediate apical NaCl reabsorption in the thick ascending limb and distal convoluted tubule, respectively. In contrast to WNK4's inhibitory activity, kinase-active WNK3 is a potent activator of both NKCC2 and NCC-mediated transport. Conversely, in its kinase-inactive state, WNK3 is a potent inhibitor of NKCC2 and NCC activity. WNK3 regulates the activity of these transporters by altering their expression at the plasma membrane. Wild-type WNK3 increases and kinase-inactive WNK3 decreases NKCC2 phosphorylation at Thr-184 and Thr-189, sites required for the vasopressin-mediated plasmalemmal translocation and activation of NKCC2 in vivo. The effects of WNK3 on these transporters and their coexpression in renal epithelia implicate WNK3 in NaCl, water, and blood pressure homeostasis, perhaps via signaling downstream of vasopressin.

0 Bookmarks
 · 
55 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Discovery of genomic mutations in WNK [With-No-Lysine (K)] kinase 1 and 4 responsible for pseudohypoaldosteronism type II (PHAII) featuring an autosomal-dominant salt-sensitive hypertension with hyperkalemia and metabolic acido-sis opens the avenue of the new understanding in renal tubular sodium (Na +) regulation. In mammalian, WNK kinases (WNK1-4) are a group of serine/threonine proteins. In in vitro studies, WNK1 and 4 could enhance the phosphorylation of SPAK [STE20 (sterile 20)/SPS1-related proline/alanine-rich kinase] and OSR1(Oxidative Stress-Response kinase 1) known as the upstream activators of NKCC2 [Na + -K + -2Cl -cotransproter 2] and NCC [Na + -Cl -cotransproter] in the thick ascending limbs and distal convoluted tubules of kidney, respectively. Several genetically-altered mice models have been created to explore the in vivo function of WNK, SPAK/OSR1 and NCC. PHAII-mutant WNK4 transgenic/knock-in mice exhibit typical PHAII phenotype with an increased phosphorylation and function of SPAK/OSR1 and NCC. On the other hand, mice with attenuated WNK4 or SPAK expression manifest Gitelman-like syndrome, the mirror images of PHAII, with a reduced phosphorylation and function of NCC. Mice with altered WNK1 expression also have abnormal blood pressure and disturbed renal Na + regulation. Polymorphisms in genes encoding WNK1, WNK4, SPAK and NCC are also associated with essential hypertension and WNK-SPAK/OSR-NCC signaling is also reported to involved in salt-sensitive hypertension. This review summarizes the important studies in the molecular pathophysiology of WNK-SPAK/OSR1-N(K)CC signaling in the kidneys from cell and transgenic animal models to human studies. Key words: hypertension, pseudohypoaldosteronism type 2, transgenic mouse, WNK, SPAK/OSR1, N(K)CC Abbreviations: NKCC, Na-K-2Cl cotransporter; NCC, thiazide-sensitive Na-Cl cotransporter; OSR1, oxidative stress re-sponse kinase 1; PHAII, pseudohypoaldosteronism type II; SPAK, Ste20-related proline alanine-rich kinase; WNK, With-No-Lysine (K) kinase.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This review summarizes the data on the functioning of carriers providing electroneutral symport of sodium, potassium, and chloride (Na+,K+,2Cl- cotransport), potassium and chloride (K+,Cl- cotransport), and sodium and chloride (K+,Cl- cotransport) as well as molecular mechanisms of the regulation of these carriers and their physiological significance. We emphasized the involvement of chloride-coupled carriers in the regulation of cell volume and intracellular chloride concentration and novel data on the role of ubiquitous isoform of Na+,K+,2Cl- cotransporter NKCC1 in regulation of vascular smooth muscle contraction and activity of GABAA receptors. Finally, we analyzed the data on activation of NKCC1 in patients with essential hypertension and its role in the long-term maintenance of elevated systemic blood pressure and myogenic response in microcirculatory beds.
    Biochemistry (Moscow) 12/2015; 79(13):1546-1561. DOI:10.1134/S0006297914130070 · 1.35 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Na/K/2Cl cotransporter NKCC2 (BSC1) is located in the apical membrane of the epithelial cells of the thick ascending limb of the loop of Henle (TAL). NKCC2 facilitates approximately 20-25% of the re-uptake of the total filtered NaCl load. NKCC2 is therefore one of the transport proteins with the highest overall reabsorptive capacity in the kidney. Consequently, even subtle changes in NKCC2 transport activity considerably alter the renal reabsorptive capacity for NaCl and eventually lead to perturbations of the salt and water homoeostasis. In addition to facilitating the bulk reabsorption of NaCl in the TAL, NKCC2 transport activity in the macula densa cells of the TAL constitutes the initial step of the tubular-vascular communication within the juxtaglomerular apparatus (JGA); this communications allows the TAL to modulate the preglomerular resistance of the afferent arteriole and the renin secretion from the granular cells of the JGA. This review provides an overview of our current knowledge with respect to the general functions of NKCC2, the modulation of its transport activity by different regulatory mechanisms, and new developments in the pathophysiology of NKCC2-dependent renal NaCl Transport.
    American journal of physiology. Renal physiology 09/2014; 307(9). DOI:10.1152/ajprenal.00432.2014 · 3.30 Impact Factor

Full-text (2 Sources)

Download
22 Downloads
Available from
May 21, 2014